The prevalence of open-angle glaucoma among blacks and whites 73 years and older -: The Salisbury Eye Evaluation glaucoma study

The prevalence of open-angle glaucoma among blacks and whites 73 years and older -: The Salisbury Eye Evaluation glaucoma study
复制标题

DOI:
10.1001/archopht.124.11.1625
复制
发表时间:
2006-11-01
影响因子:
--
通讯作者:
West, Sheila K.
West, Sheila K.
中科院分区:
其他
文献类型:
--
作者:
Friedman, David S.;Jampel, Henry D.;West, Sheila K.

文献摘要

被引文献

相似文献

目的:为了确定青光眼的患病率在黑人和白色人73岁及以上。设计:参与者在第四轮的人口为基础的研究,索尔兹伯里眼睛评估,进行了检查。主要的结局措施是青光眼,视神经损伤和视野损失或明显的青光眼性视神经病变的基础上没有一个可用的,可靠的,可重复的visualfield.Results:共1250人(95.9%的合格)参加,1233(98.6%)的人同意筛选和眼科检查。73岁和74岁的白色个体的开角型青光眼患病率(95%置信区间)为3.4%(0.5%-6.4%),75岁及以上个体的患病率增加至9.4%(7.4%-11.5%)。在75岁以上的人群中,患病率没有增加。在黑人中,患病率(95%的置信区间)为5.7%(0%-11.9%),在那些年龄在73和74岁和23.2%(17.8%-28.5%),在那些75岁及以上的老年人。结论:许多老年人有开角型青光眼,黑人75岁及以上有显着高于白人的比率。这些发现对公共卫生倡议具有重要意义,其中筛查计划可能是有益的。
Objective: To determine the prevalence of glaucoma among black and white persons 73 years and older.Design: Participants in the fourth round of a population-based study, the Salisbury Eye Evaluation, were examined. The main outcome measure was glaucoma, based on optic nerve damage and visual field loss or obvious glaucomatous optic neuropathy without an available, reliable, reproducible visual field.Results: A total of 1250 individuals (95.9% of those eligible) participated, 1233 (98.6%) of whom agreed to screening and an eye examination. The prevalence (95% confidence interval) of open-angle glaucoma was 3.4% (0.5%-6.4%) for white individuals aged 73 and 74 years, increasing to 9.4% (7.4%-11.5%) for those 75 years and older. There was no increasing prevalence in those older than 75 years. Among black persons, the prevalence (95% confidence interval) was 5.7% (0%-11.9%) in those aged 73 and 74 years and 23.2% (17.8%-28.5%) in those 75 years and older.Conclusions: Many older individuals have open-angle glaucoma, and black persons 75 years and older have substantially higher rates than whites. These findings have important implications for public health initiatives, in which screening programs may be of benefit.